Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes

Acta Neurol Belg. 1998 Dec;98(4):322-6.

Abstract

Anti-GQ1b antibodies were assayed by an enzyme-linked immunosorbent assay in sera from patients with non-neurological disorders (N = 20), and with various neurological disorders (N = 59), including nine cases of Miller Fisher syndrome, 16 cases of Guillain-Barré syndrome and one case of acute post-infectious ophthalmoparesis. Such antibodies were found in most cases (8 out of 9) of Miller Fisher syndrome, and at very high titres, in one case of Guillain-Barré syndrome characterised by an initial ophthalmoparesis, and in the case of isolated post-infectious ophthalmoparesis. The latter was characterised by a long-lasting occurrence of these antibodies. Anti-GQ1b antibodies are specific for an immune-mediated neuropathy of the cranial, especially oculomotor, nerves.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies / blood
  • Autoantibodies / immunology*
  • Autoantigens / immunology*
  • Autoimmune Diseases / etiology
  • Autoimmune Diseases / immunology*
  • Campylobacter Infections / complications
  • Campylobacter Infections / immunology
  • Campylobacter jejuni
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gangliosides / immunology*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Immunoglobulin M / blood
  • Immunoglobulin M / immunology
  • Male
  • Middle Aged
  • Miller Fisher Syndrome / etiology
  • Miller Fisher Syndrome / immunology*
  • Nervous System Diseases / immunology
  • Ophthalmoplegia / etiology
  • Ophthalmoplegia / immunology
  • Polyradiculoneuropathy / etiology
  • Polyradiculoneuropathy / immunology*
  • Virus Diseases / complications
  • Virus Diseases / immunology

Substances

  • Autoantibodies
  • Autoantigens
  • Gangliosides
  • Immunoglobulin G
  • Immunoglobulin M
  • GQ1b ganglioside